Does treatment of paradoxical vocal fold movement disorder decrease asthma medication use?

2016 ◽  
Vol 127 (7) ◽  
pp. 1531-1537 ◽  
Author(s):  
Scott Kramer ◽  
Brad deSilva ◽  
L. Arick Forrest ◽  
Laura Matrka
Keyword(s):  
Movement Disorder ◽  
Vocal Fold ◽  
Medication Use ◽  
Asthma Medication ◽  
Paradoxical Vocal Fold Movement

scholarly journals Visual biofeedback for paradoxical vocal fold motion (PVFM)

2021 ◽  
Vol 50 (1) ◽  
Author(s):  
Rachelle Alyce LeBlanc ◽  
Daniel Aalto ◽  
Caroline C. Jeffery
Keyword(s):  
Vocal Fold ◽  
Medication Use ◽  
Vocal Folds ◽  
Asthma Medication ◽  
Secondary Outcome ◽  
Post Intervention ◽  
Visual Biofeedback ◽  
Vocal Fold Motion ◽  
Paradoxical Vocal Fold Motion

Abstract Objectives Paradoxical vocal fold motion (PVFM) is a common condition where the vocal folds inappropriately adduct during inspiration. This results in dyspnea and occasionally significant distress. The condition is thought to be primarily functional, with behavioural therapy considered mainstay in the non-acute setting. However, practice variations and limited access to speech language pathology (SLP) services can pose management challenges. We aimed to examine the efficacy of surgeon performed visual biofeedback as first-line treatment for PVFM. Study design Prospective, non-randomized, non-comparative clinical study. Methods Adult patients referred for possible PVFM and congruent laryngoscopy findings over a two-year period were included. Patients were excluded if they presented in acute distress, had alternate diagnosis to explain symptomology and/or coexisting untreated lower respiratory pathology. Patients underwent immediate surgeon-performed visual biofeedback on the same visit day. The primary outcome of interest was change in Dyspnea Index (DI) scores pre- and post-intervention 3 months follow-up. The secondary outcome measured was change in asthma medication use from baseline to follow-up. Results Of 34 patients presenting, 25 met inclusion criteria. Of these, 72% were female with an average age of 36.9 ± 14.1. Approximately 48% of patients had a diagnosis of well-controlled asthma at presentation and co-morbid psychiatric diagnoses were common (52%). Pre- and post-intervention analysis showed significant improvement in DI scores (p < 0.001) and reduction in bronchodilator use (p = 0.003). Conclusion This is a prospective study that evaluates the role of visual biofeedback in PVFM patients. Our data suggests that visual biofeedback effectively reduces short-term subjective symptoms and asthma medication use. Level of evidence 3 Graphical abstract

scholarly journals Post-COVID-19 paradoxical vocal fold movement disorder

2020 ◽  
Author(s):  
Jérôme René Lechien ◽  
Marta P. Circiu ◽  
Lise Crevier-Buchman ◽  
Stephane Hans
Keyword(s):  
Movement Disorder ◽  
Vocal Fold ◽  
Paradoxical Vocal Fold Movement

Reduced Asthma Medication Use after Treatment of Pediatric Paradoxical Vocal Fold Motion Disorder

2020 ◽  
Author(s):  
Ryan Ivancic ◽  
Laura Matrka ◽  
Gregory Wiet ◽  
Amy Puckett ◽  
Jennifer Haney ◽  
...  
Keyword(s):  
Vocal Fold ◽  
Medication Use ◽  
Asthma Medication ◽  
Vocal Fold Motion ◽  
Paradoxical Vocal Fold Motion

Laryngeal sensory deficits in patients with chronic cough and paradoxical vocal fold movement disorder

2010 ◽  
Vol 120 (8) ◽  
pp. 1576-1581 ◽  
Author(s):  
Thomas Murry ◽  
Ryan C. Branski ◽  
Kathy Yu ◽  
Sabrina Cukier-Blaj ◽  
Suzy Duflo ◽  
...  
Keyword(s):  
Movement Disorder ◽  
Chronic Cough ◽  
Vocal Fold ◽  
Sensory Deficits ◽  
Paradoxical Vocal Fold Movement

Can the Expiratory Disproportion Index Distinguish PVFMD from Subglottic Stenosis in Obese Patients?

2021 ◽  
pp. 000348942199015
Author(s):  
Kevin Calamari ◽  
Stephen Politano ◽  
Laura Matrka
Keyword(s):  
Vocal Fold ◽  
Forced Expiratory Volume ◽  
Subglottic Stenosis ◽  
Obese Patients ◽  
Level Of Evidence ◽  
Prior Literature ◽  
The Mean ◽  
Sensitivity Specificity ◽  
Paradoxical Vocal Fold Movement ◽  
Rule Out

Objectives: Expiratory disproportion index (EDI) is the ratio of forced expiratory volume in 1 second (FEV1) divided by peak expiratory flow rate (PEFR) multiplied by 100. Prominent EDI (>50) values can differentiate subglottic stenosis (SGS) from paradoxical vocal fold movement disorder (PVFMD), but this has not been verified when considering body habitus. We hypothesize that the predictive value of elevated EDI in differentiating SGS from PVFMD will be lower in obese patients than non-obese patients. Methods: Patients ≥ 18 years old with recorded PFT values, BMI, and airway imaging were reviewed retrospectively from 01/2011 to 10/2018. EDI was recorded for 4 cohorts: non-obese/SGS, non-obese/ PVFMD, obese/SGS, and obese/ PVFMD, to determine the mean EDI and the sensitivity/specificity of an elevated EDI. Results: Mean EDI values were 69.32 and 48.38 in the non-obese SGS and PVFMD groups, respectively ( P < .01). They were 58.89 and 47.67 in the obese SGS and PVFMD groups, respectively ( P < .05). At a threshold of >50, EDI had a sensitivity of 90.0% and specificity of 51.6% in differentiating between SGS and PVFMD cases in non-obese patients and 51.6% and 63.6% in obese patients. Conclusion: Prior literature has established that EDI can distinguish SGS from PVFMD in the general population. Our results show that the mean EDI values were significantly different in both cohorts, but an elevated EDI was not as sensitive at identifying SGS cases in obese patients. This suggests that the EDI should be used with caution in obese patients and should not be relied upon to rule out SGS. Level of Evidence: 3.

scholarly journals Medication Errors in Adolescents Using Asthma Controller Medications

2020 ◽  
Vol 7 ◽  
pp. 2333794X2098134
Author(s):  
Henry Clark ◽  
Delesha Carpenter ◽  
Kathleen Walsh ◽  
Scott A. Davis ◽  
Nacire Garcia ◽  
...  
Keyword(s):  
Medical Record ◽  
Medication Errors ◽  
Medication Use ◽  
Persistent Asthma ◽  
Cross Sectional Study ◽  
Asthma Medication ◽  
Sectional Study ◽  
Cross Sectional ◽  
Controller Medication ◽  
Controller Medications

The purpose of this study was to describe the number and types of errors that adolescents and caregivers report making when using asthma controller medications. A total of 319 adolescents ages 11 to 17 with persistent asthma and their caregivers participated in this cross-sectional study. Adolescent and caregiver reports of asthma medication use were compared to the prescribed directions in the medical record. An error was defined as discrepancies between reported use and the prescribed directions. About 38% of adolescents reported 1 error in using asthma controller medications, 16% reported 2 errors, and 5% reported 3 or more errors. About 42% of caregivers reported 1 error in adolescents using asthma controller medications, 14% reported 2 errors, while 6% reported 3 or more errors. The type of error most frequently reported by both was not taking the medication at all. Providers should ask open-ended questions of adolescents with asthma during visits so they can detect and educate families on how to overcome errors in taking controller medication use.

scholarly journals Asthma medication use during pregnancy, wheeze and estimated exposure to ambient nitrogen dioxide

2014 ◽  
Vol 45 (2) ◽  
pp. 538-540 ◽  
Author(s):  
Janneane F. Gent ◽  
Julie M. Kezik ◽  
Melissa E. Hill ◽  
Lisa A. McKay ◽  
Theodore R. Holford ◽  
...  
Keyword(s):  
Nitrogen Dioxide ◽  
Medication Use ◽  
Asthma Medication
Sign in / Sign up

Export Citation Format

Share Document